ZA966254B - Use of unsubstituted and substituted n-(pyrrol-1-y)pyridinamines as anticonvulsant agents. - Google Patents

Use of unsubstituted and substituted n-(pyrrol-1-y)pyridinamines as anticonvulsant agents.

Info

Publication number
ZA966254B
ZA966254B ZA9606254A ZA966254A ZA966254B ZA 966254 B ZA966254 B ZA 966254B ZA 9606254 A ZA9606254 A ZA 9606254A ZA 966254 A ZA966254 A ZA 966254A ZA 966254 B ZA966254 B ZA 966254B
Authority
ZA
South Africa
Prior art keywords
pyridinamines
pyrrol
unsubstituted
substituted
anticonvulsant agents
Prior art date
Application number
ZA9606254A
Other languages
English (en)
Inventor
Francis Paul Huger
Craig P Smith
Sathapana Kongsamut
Lei Tang
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA966254B publication Critical patent/ZA966254B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9606254A 1995-07-27 1996-07-23 Use of unsubstituted and substituted n-(pyrrol-1-y)pyridinamines as anticonvulsant agents. ZA966254B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50807195A 1995-07-27 1995-07-27

Publications (1)

Publication Number Publication Date
ZA966254B true ZA966254B (en) 1997-02-11

Family

ID=24021262

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606254A ZA966254B (en) 1995-07-27 1996-07-23 Use of unsubstituted and substituted n-(pyrrol-1-y)pyridinamines as anticonvulsant agents.

Country Status (19)

Country Link
EP (1) EP0840609B1 (da)
JP (1) JP4189029B2 (da)
KR (1) KR100445629B1 (da)
CN (1) CN1184969C (da)
AR (1) AR003471A1 (da)
AT (1) ATE218343T1 (da)
AU (1) AU696007B2 (da)
CA (1) CA2225156C (da)
DE (1) DE69621617T2 (da)
DK (1) DK0840609T3 (da)
ES (1) ES2174081T3 (da)
IL (1) IL122845A0 (da)
MX (1) MX9800774A (da)
NO (1) NO315148B1 (da)
NZ (1) NZ312577A (da)
PT (1) PT840609E (da)
TW (1) TW464497B (da)
WO (1) WO1997004777A1 (da)
ZA (1) ZA966254B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032599A (en) * 1986-11-12 1991-07-16 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-l-yl)pyridinamines
DE3852335T2 (de) * 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Also Published As

Publication number Publication date
CA2225156A1 (en) 1997-02-13
JPH11510159A (ja) 1999-09-07
HK1015687A1 (en) 1999-10-22
NO980334D0 (no) 1998-01-26
NO315148B1 (no) 2003-07-21
NZ312577A (en) 1999-08-30
WO1997004777A1 (en) 1997-02-13
DE69621617D1 (de) 2002-07-11
DE69621617T2 (de) 2003-01-02
PT840609E (pt) 2002-10-31
ATE218343T1 (de) 2002-06-15
ES2174081T3 (es) 2002-11-01
KR19990035973A (ko) 1999-05-25
AU696007B2 (en) 1998-08-27
TW464497B (en) 2001-11-21
AR003471A1 (es) 1998-08-05
CN1184969C (zh) 2005-01-19
DK0840609T3 (da) 2002-09-30
AU6454796A (en) 1997-02-26
CA2225156C (en) 2003-06-10
MX9800774A (es) 1998-04-30
EP0840609B1 (en) 2002-06-05
IL122845A0 (en) 1998-08-16
JP4189029B2 (ja) 2008-12-03
CN1191486A (zh) 1998-08-26
NO980334L (no) 1998-03-26
EP0840609A1 (en) 1998-05-13
KR100445629B1 (ko) 2004-10-14

Similar Documents

Publication Publication Date Title
HU9601475D0 (en) Substituted n-(indolo-2-carbonyl)-glycinamides and derivatives as antidiabetic agents
PL314603A1 (en) Substituted n-(indolo-2-carbonyl)-beta-alaninamides and their derivatives as antidiabetic agents
GR3029893T3 (en) N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists
GB9511694D0 (en) Benzamide derivatives
NO981133D0 (no) Ikke-reseptormedierte kontrastmidler
GB9526560D0 (en) Use of 2-Amino-Heterocycles
ZA976222B (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
ZA962768B (en) Benzonitriles and benzofluorides
GB9501560D0 (en) Contrast agents
NO953638D0 (no) Gass-genererende kontrastmidler
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
ZA957113B (en) Use of N-substituted pyhenothiazines
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
ZA9610433B (en) Medical use of proteases.
GB2307479B (en) Mixtures of monoazopyridone dyes
ZA966254B (en) Use of unsubstituted and substituted n-(pyrrol-1-y)pyridinamines as anticonvulsant agents.
PL314638A1 (en) Novel ethyloamidofluorenes and pharmaceutic agent
IL118629A0 (en) N-Substituted cis-N-propenyl-acetemides their preparation and use
SI0840609T1 (en) Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
ZA965678B (en) Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
GB2307480B (en) Mixtures of monoazopyridone dyes
IL151521A0 (en) Use of unsubstituted and substituted n-(pyrrol-1-yl) pyridinamines in the preparation of anticonvulsant pharmaceutical compositions, and pharmaceutical compositions comprising them
GB9421288D0 (en) Use of an enzyme
GB9421290D0 (en) Use of an enzyme
IL117844A0 (en) Use of (s)-adenosyl-l-methionine